Célia Bouacha graduated from the University of Strasbourg with a master’s degree in chemistry, biology and drug in 2022. She performed several internships in medicinal chemistry in academic research. In particular, she contributed to various projects such as the synthesis of a therapeutic molecule for the treatment of autism and the synthesis of a photosensitive molecule for the study of neurotransmission. She is currently doing a PhD thesis on the development of heterobivalent ligands to study the heterodimerization of the ghrelin receptor (GHSR) and the dopamine D2 receptor (D2R), under the supervision of Dr Séverine Denoyelle and Dr Sonia Cantel.